Urinary Flow Meters Market Size, Share & COVID-19 Impact Analysis, By Type (PC Based Urinary Flow Meters and Non-PC Based Urinary Flow Meters), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2023-2030

The urinary flow meters market size was valued at USD 18.5 million in 2022 and is projected to grow from USD 19.9 million in 2023 to USD 34.9 million by 2030, exhibiting a CAGR of 8.3% during 2023-2030. North America dominated the global market with a share of 40% in 2022.

Uroflowmeters helps in the diagnosis of diseases such as urine leakage, urine retention, and benign prostate hyperplasia. These devices are commonly used in specialty clinics and hospitals for the evaluation of the functionality of the urinary system and diagnosis of various urological conditions. The various benefits associated with these products, which include their easy-to-use features, improved handling, and accurate analysis of urine flow, which have increased the adoption of these products.

The rising prevalence of urinary tract disorders will positively influence the urinary flow meters market growth. Furthermore, the growing demand for high-quality devices and the rising number of product launches by the market players are expected to boost market growth over 2023-2030.

COVID-19 IMPACT

The Pandemic Negatively Impacted Market Players’ Revenue Due to Lower Patient Volume in Clinics

The emergence of the COVID-19 pandemic led to a decline in the demand for products used by urologists due to lower patient volumes. The reallocation of healthcare resources, supply chain disruptions, decreased patient visits to clinics, and other major parameters impacted the sales of products. Additionally, market key players recorded a significant decline in their revenues due to the outbreak of COVID-19.

The negative growth of the market was due to the decline in the number of patients visiting hospitals and specialty clinics for the diagnosis of urinary tract disorders.

• For instance, according to the study published by Elsevier Inc. in July 2021, there was a 50.0% drop in visit volume to urology services from March 2020 to April 2020 in the U.S.

Additionally, several hospital beds, rooms, and even urologists shifted toward the treatment of COVID-19, leading to a decline in the demand for uroflometers.

• For instance, according to the survey published by NCBI in August 2020, the bed occupancy in the urological departments was reduced by 48.6% to hospitalize COVID-19 patients.

The resumption of a significant number of surgical procedures and patient visits in 2020 and 2021 contributed to the market falling back to the pre-pandemic year in 2022.

LATEST TRENDS

Increased Transition from Non-PC Based Products to PC Based Products 

The urinary flow meter market is continuously evolving with the advent of advanced products. These innovations have shifted from Non-PC Based flowmeters to PC Based products. PC Based devices offer several advantages, which include enhanced accuracy and precision in measuring urine flow rates. They can also seamlessly integrate with electronic medical records (EMRs) and other clinical systems, facilitating efficient patient data tracking and enabling healthcare professionals to make well-informed decisions.

Furthermore, the market players are focusing on developing innovative PC Based devices to enhance their product offerings and attract a wider customer base by providing improved diagnosis facilities to urologists for the evaluation of several disorders, including urinary tract diseases. Additionally, as the medical device industry continues to embrace digital technologies, it is expected that the market for PC Based devices will continue to grow robustly in the coming years.

DRIVING FACTORS

Growing Prevalence of Urological Disorders to Drive the Product Demand

The market is anticipated to experience significant growth in the coming years due to the increasing prevalence of urological diseases. There has been an increase in the adoption of these products due to the growing prevalence of urological diseases, such as benign prostatic hyperplasia (BPH), urinary incontinence, enlarged prostates, prostate cancer, and bladder cancer.

• For instance, according to the study published by the journal Nursing Open in April 2023, in China, the prevalence of stress urinary incontinence (SUI) among adult women was 22.2%. Furthermore, 16.2% and 6.0% had mild SUI and moderate-to-severe SUI among adult Chinese women.

Similar trends of higher prevalence of urinary incontinence among women have been observed globally, leading to increased demand for these products.

The rising prevalence of urological diseases has increased the adoption of these devices for diagnosis in hospitals & specialty clinics. Furthermore, many market players are focusing on the development and introduction of advanced devices to diagnose patients with urological diseases.

Growing Burden of Geriatric Population to Drive Market Growth

The prevalence of urological disorders is rising globally, primarily due to the growing burden of the aging population. The risk of bladder problems such as urine leakage, retention, and benign prostate hyperplasia (BPH) is high in geriatric population.  According to an article published in the Eurostat in 2022, more than one-fifth (20.8%) of the European Union population was comprised of ages 65 and over in 2021. So, the rising geriatric population is expected to contribute to the robust demand for these products in the future. BPH is a common urological disorder among aging men, which further contributes to the demand for these products. The rising male geriatric population and the increasing incidence of BPH in this group are anticipated to fuel the demand for these devices.

These products are used in the diagnosis of various urinary tract disorders, including BPH, bladder neck obstruction, bladder neuromuscular dysfunction cystometry, and neurogenic bladder, by the measurement of urine flow rates. The increasing trend of home healthcare is expected to boost the adoption of these devices among patients who prefer to receive care at home. The growing geriatric population, increasing prevalence of urology diseases, and technological advancements are expected to drive the growth of the market in the coming years.

RESTRAINING FACTORS

Inadequate Awareness and High Costs of Urinary Flow Meters to Hamper Market Growth

In developing countries, there has been an increase in the number of uroflowmetry testing procedures and the prevalence of urology diseases. However, several factors, such as lack of awareness, comparatively lower healthcare expenditure in emerging countries, and high costs of these products, are expected to impede the market growth.

In emerging countries, there is a lack of awareness regarding these devices, which can be due to the limited access to healthcare facilities and the lesser importance of monitoring urinary health. As a result, the adoption rate of these products remains low, hindering the market growth.

Additionally, the high costs of these products pose a significant barrier to their adoption in hospitals and specialty clinics. The prices of these devices can vary depending on their type and features, with certain advanced products costing several thousand dollars. Hence, factors such as high costs and insufficient awareness are responsible for the lower adoption rates of these products.

SEGMENTATION

By Type Analysis

Rising Prevalence of Urologic Diseases to Drive PC Based Urinary Flow Meters Segment Growth

Based on the type, the market is bifurcated into PC Based urinary flow meters and Non-PC Based urinary flow meters.

PC Based urinary flow meters segment captured the highest global urinary flow meters market share in 2022 and is estimated to record the fastest CAGR over 2023-2030. The large share of the segment is attributed to the growing prevalence of urologic diseases coupled with the high demand for these products, especially amongst developed countries. The increasing adoption of these products, coupled with the market players bringing in new products, such as wireless connection type products to the market, is driving the segmental growth.

The Non-PC Based urinary flow meters segment is projected to expand at a substantial CAGR during the forecast period. This segmental growth is due to the growing introduction and development of products by companies for rapid and easy analysis of patients suffering from urinary problems. Furthermore, the market players are focusing on various strategies to expand their product offerings in the segment, thereby increasing the segmental growth during the forecast period.

By End-user Analysis

Hospitals to Hold Major Share in 2022 Due To Large Number Of Patient Visits

Based on end-user, the market is segregated into hospitals, specialty clinics, and others.

The hospitals segment dominated the market share in 2022 and is projected to register a notable CAGR during 2023-2030. The higher segment share is attributed to the growing adoption of these products in hospitals. Furthermore, the large number of patient visits in hospitals for the diagnosis of urological disorders is anticipated to boost the segment’s growth during the forecast period.

• For instance, according to the GLOBOCAN Report 2020, the prevalence of bladder cancer in Europe for the last five years is 38.1%. Such increasing prevalence of critical diseases is expected to boost the demand for urinary flow meters in hospitals.

The specialty clinics segment is expected to grow at the fastest CAGR over 2023-2030. The segmental growth is due to the increase in the number of urologists opening their independent clinics and increasing investments in the innovation of advanced diagnostics for urological disorders. Moreover, the rising adoption of urine flow analyzers and the rising number of uroflowmetry tests in urinary incontinence patients in these medical facilities is driving the segment’s growth of the urine flow meters market.

REGIONAL INSIGHTS

North America generated USD 7.4 million in the market in terms of market revenue in 2022. The region is anticipated to dominate the global market owing to a surge in the launches of advanced products by market players and widespread adoption of PC Based products in the region. Moreover, a large population base with prostate cancer, benign prostatic hyperplasia, and bladder cancer, and the increase in the number of patient visits for diagnosis of these diseases will foster market growth in the region.

Europe held a substantial market share in 2022, and it is projected to record a robust CAGR during the forecast period. The wide occurrence of urology disorders and the increase in the number of adults undergoing diagnosis for these disorders in the region is anticipated to drive regional growth. Furthermore, the presence of established market players is anticipated to propel the regional market forward.

The market across Asia Pacific is anticipated to have the highest CAGR from 2023 to 2030. The highest CAGR of the region can be attributed to the increasing adoption of these products coupled with the growing geriatric population across the region. Moreover, increasing investments by the companies in the region is expected to drive the market growth.

The rest of the world accounted for a significant share of the market due to the growing population suffering from urological disorders, rising healthcare investments, and increasing launches of technologically advanced products by market players in this region.

KEY INDUSTRY PLAYERS

Growing Key Players Focus on Mergers & Acquisitions to Drive Market Growth

Laborie, MEDKONSULT Medical Technology, and Medica S.p.A are considered to be some of the leading players in the market. The dominance of these players is attributable to the strong direct and indirect presence of these companies in the global market, coupled with a diversified and high-quality product portfolio. These market players are focusing on the establishment of new subsidiaries, mergers, acquisitions, and product launches to penetrate new markets.

Other companies operating in the global market include Prometheus, tic Medizintechnik GmbH & Co. KG, MINZE HEALTH, Apex MediTech, NOVAmedtek, Status Medical Equipments India Pvt Limited, and other small & medium-sized players. These companies are focusing on various strategic developments such as partnerships, collaborations, and new product launches. Furthermore, a growing focus on introducing and developing innovative products for untapped segments of the market is expected to boost their share in the market.

LIST OF KEY COMPANIES PROFILED:

• MINZE HEALTH (Belgium)


• Oruba Technology & Innovation (Turkey)


• tic Medizintechnik GmbH & Co. KG (Germany)


• Potent Medical (China)


• Laborie (U.S.)


• Apex MediTech (India)


• Status Medical Equipments India Pvt Limited (India)


• Medica S.p.A (Italy)

KEY INDUSTRY DEVELOPMENTS:

• April 2023 - Status Medical Equipments India Pvt Limited was granted the manufacturing license for their flagship Class B devices (Uroflowmeter, Urodynamic Measurement System, and Pneumatic Lithotripter) by the Central Drugs Standard Control Organization (CDSCO).


• April 2023- MINZE HEALTH announced its active participation in the European Society for Pediatric Urology organized in Lisbon, Portugal, to highlight its home uroflow urinary flow meter for children with urinary tract infection


• December 2022- MINZE HEALTH announced that White Fund, Capricorn Partners, and PMW have jointly invested USD 4.1 million in the company to further scale its digital health solutions for the treatment of urinary tract infections.


• November 2021- Oruba Technology & Innovation introduced the first self-operating uroflowmeter globally. The device is an IoT-supported uroflowmeter that increases patient comfort and allows for time-saving and contactless screenings.


• April 2021- Apex MediTech launched the digiFLOW S, an advanced standalone uroflometry system designed for routine urinary flow studies.

REPORT COVERAGE

The global urine flow meters market report includes a detailed market overview. The global urinary flow meters market forecast includes the segments of type, end-user, and geography. It focuses on industry overview and market dynamics such as the drivers, restraints, opportunities, and trends. Besides this, the report provides information related to key industry developments such as mergers and acquisitions and technological advancements in the market. Furthermore, the report focuses on the epidemiology of key urology disorders in key countries. In addition, the impact of COVID-19 and the industry overview during the pandemic are covered in the report.

Report Scope & Segmentation